Systemic capillary leak syndrome (SCLS) is a very rare and lethal disease characterized by hemoconcentration and hypoalbuminemia caused by reversible plasma extravasation. The underlying cause for SCLS remains largely unknown and acute treatment has remained mainly supportive. Prophylaxis with intravenous immunoglobulin (IVIG) has been shown to successfully prevent further episodes in affected patients. We reported a case of SCLS in a patient who presented to our hospital with COVID-19 and developed profound shock.
A case of chronic systemic capillary leak syndrome (SCLS) exacerbated during SARS-CoV2 infection / Concistre, A.; Alessandri, F.; Rosato, E.; Pugliese, F.; Muscaritoli, M.; Letizia, C.. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 25:19(2021), pp. 5922-5927. [10.26355/eurrev_202110_26868]
A case of chronic systemic capillary leak syndrome (SCLS) exacerbated during SARS-CoV2 infection
CONCISTRE A.;ALESSANDRI F.;ROSATO E.;PUGLIESE F.;MUSCARITOLI M.;LETIZIA C.
2021
Abstract
Systemic capillary leak syndrome (SCLS) is a very rare and lethal disease characterized by hemoconcentration and hypoalbuminemia caused by reversible plasma extravasation. The underlying cause for SCLS remains largely unknown and acute treatment has remained mainly supportive. Prophylaxis with intravenous immunoglobulin (IVIG) has been shown to successfully prevent further episodes in affected patients. We reported a case of SCLS in a patient who presented to our hospital with COVID-19 and developed profound shock.| File | Dimensione | Formato | |
|---|---|---|---|
|
Pugliese_Systemic-capillary-leak-syndrome_2021.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.14 MB
Formato
Adobe PDF
|
1.14 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
